554 related articles for article (PubMed ID: 34526087)
61. COVID-19-Associated Pulmonary Aspergillosis at an Academic Medical Center in the Midwestern United States.
Wasylyshyn AI; Wasylyshyn GR; Linder KA; Miceli MH
Mycopathologia; 2021 Aug; 186(4):499-505. PubMed ID: 34143393
[TBL] [Abstract][Full Text] [Related]
62. COVID-19-associated invasive pulmonary aspergillosis in a tertiary care center in Mexico City.
Vélez Pintado M; Camiro-Zúñiga A; Aguilar Soto M; Cuenca D; Mercado M; Crabtree-Ramirez B;
Med Mycol; 2021 Jul; 59(8):828-833. PubMed ID: 33724423
[TBL] [Abstract][Full Text] [Related]
63. [COVID-19-associated pulmonary aspergillosis in critically ill patients: experience of a Chilean public hospital].
Araya-Rojas F; Lasso-Barreto M
Rev Chilena Infectol; 2021 Dec; 38(6):754-760. PubMed ID: 35506848
[TBL] [Abstract][Full Text] [Related]
64. Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU): a randomised, open-label, proof-of-concept trial.
Vanderbeke L; Janssen NAF; Bergmans DCJJ; Bourgeois M; Buil JB; Debaveye Y; Depuydt P; Feys S; Hermans G; Hoiting O; van der Hoven B; Jacobs C; Lagrou K; Lemiale V; Lormans P; Maertens J; Meersseman P; Mégarbane B; Nseir S; van Oers JAH; Reynders M; Rijnders BJA; Schouten JA; Spriet I; Thevissen K; Thille AW; Van Daele R; van de Veerdonk FL; Verweij PE; Wilmer A; Brüggemann RJM; Wauters J;
Intensive Care Med; 2021 Jun; 47(6):674-686. PubMed ID: 34050768
[TBL] [Abstract][Full Text] [Related]
65. A Regional Observational Study on COVID-19-Associated Pulmonary Aspergillosis (CAPA) within Intensive Care Unit: Trying to Break the Mold.
Lupia T; Montrucchio G; Gaviraghi A; Musso G; Puppo M; Bolla C; Shbaklo N; Rizzello B; Della Selva A; Concialdi E; Rumbolo F; Barbui AM; Brazzi L; De Rosa FG; Corcione S
J Fungi (Basel); 2022 Nov; 8(12):. PubMed ID: 36547597
[TBL] [Abstract][Full Text] [Related]
66. Evaluation of posaconazole antifungal prophylaxis in reducing the incidence of invasive aspergillosis in patients with acute myeloid leukemia.
Le Clech L; Uguen M; Quinio D; Nevez G; Couturier MA; Ianotto JC; Berthou C; Guillerm G; Le Bars H; Payan C; Narbonne V; Baron R; Saliou P
Curr Res Transl Med; 2020 Jan; 68(1):23-28. PubMed ID: 31787568
[TBL] [Abstract][Full Text] [Related]
67. Coronavirus Disease 2019-Associated Pulmonary Aspergillosis in Mechanically Ventilated Patients.
Permpalung N; Chiang TP; Massie AB; Zhang SX; Avery RK; Nematollahi S; Ostrander D; Segev DL; Marr KA
Clin Infect Dis; 2022 Jan; 74(1):83-91. PubMed ID: 33693551
[TBL] [Abstract][Full Text] [Related]
68. COVID-19-associated pulmonary aspergillosis in patients with severe SARS-CoV-2 infection: A single-center observational study from Greece.
Ouranos K; Tsakiri K; Massa E; Dourliou V; Mouratidou C; Soundoulounaki S; Mouloudi E
Ann Thorac Med; 2023; 18(3):116-123. PubMed ID: 37663880
[TBL] [Abstract][Full Text] [Related]
69. Aspergillosis in Critically Ill Patients with and Without COVID-19 in a Tertiary Hospital in Southern Brazil.
Trápaga MR; Poester VR; Basso RP; Blan BDS; Munhoz LS; Pasqualotto AC; Werner TDF; Figurelli ML; Stevens DA; von Groll A; Xavier MO
Mycopathologia; 2024 Jun; 189(3):48. PubMed ID: 38847987
[TBL] [Abstract][Full Text] [Related]
70. Incidence and Risk Factors of COVID-19-Associated Pulmonary Aspergillosis in Intensive Care Unit-A Monocentric Retrospective Observational Study.
Gregoire E; Pirotte BF; Moerman F; Altdorfer A; Gaspard L; Firre E; Moonen M; Fraipont V; Ernst M; Darcis G
Pathogens; 2021 Oct; 10(11):. PubMed ID: 34832526
[TBL] [Abstract][Full Text] [Related]
71. COVID-19-associated pulmonary aspergillosis in a Japanese man: A case report.
Imoto W; Himura H; Matsuo K; Kawata S; Kiritoshi A; Deguchi R; Miyashita M; Kaga S; Noda T; Yamamoto K; Yamada K; Uchida K; Nishimura T; Yamamoto H; Mizobata Y; Kakeya H
J Infect Chemother; 2021 Jun; 27(6):911-914. PubMed ID: 33674201
[TBL] [Abstract][Full Text] [Related]
72. COVID-19 associated pulmonary aspergillosis.
Koehler P; Cornely OA; Böttiger BW; Dusse F; Eichenauer DA; Fuchs F; Hallek M; Jung N; Klein F; Persigehl T; Rybniker J; Kochanek M; Böll B; Shimabukuro-Vornhagen A
Mycoses; 2020 Jun; 63(6):528-534. PubMed ID: 32339350
[TBL] [Abstract][Full Text] [Related]
73. Corticosteroids as risk factor for COVID-19-associated pulmonary aspergillosis in intensive care patients.
Leistner R; Schroeter L; Adam T; Poddubnyy D; Stegemann M; Siegmund B; Maechler F; Geffers C; Schwab F; Gastmeier P; Treskatsch S; Angermair S; Schneider T
Crit Care; 2022 Jan; 26(1):30. PubMed ID: 35090528
[TBL] [Abstract][Full Text] [Related]
74. Accuracy of galactomannan testing on tracheal aspirates in COVID-19-associated pulmonary aspergillosis.
Roman-Montes CM; Martinez-Gamboa A; Diaz-Lomelí P; Cervantes-Sanchez A; Rangel-Cordero A; Sifuentes-Osornio J; Ponce-de-Leon A; Gonzalez-Lara MF
Mycoses; 2021 Apr; 64(4):364-371. PubMed ID: 33217784
[TBL] [Abstract][Full Text] [Related]
75. Risk factors and clinical impact of COVID-19-associated pulmonary aspergillosis: Multicenter retrospective cohort study.
Lee R; Cho SY; Lee DG; Ahn H; Choi H; Choi SM; Choi JK; Choi JH; Kim SY; Kim YJ; Lee HJ
Korean J Intern Med; 2022 Jul; 37(4):851-863. PubMed ID: 35611611
[TBL] [Abstract][Full Text] [Related]
76. COVID-19-Associated Pulmonary Aspergillosis in Russia.
Shadrivova O; Gusev D; Vashukova M; Lobzin D; Gusarov V; Zamyatin M; Zavrazhnov A; Mitichkin M; Borzova Y; Kozlova O; Desyatik E; Burygina E; Ignatyeva S; Oganesyan E; Vasilyeva N; Klimko N; Working Group
J Fungi (Basel); 2021 Dec; 7(12):. PubMed ID: 34947041
[TBL] [Abstract][Full Text] [Related]
77. Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance.
Koehler P; Bassetti M; Chakrabarti A; Chen SCA; Colombo AL; Hoenigl M; Klimko N; Lass-Flörl C; Oladele RO; Vinh DC; Zhu LP; Böll B; Brüggemann R; Gangneux JP; Perfect JR; Patterson TF; Persigehl T; Meis JF; Ostrosky-Zeichner L; White PL; Verweij PE; Cornely OA; ; ; ; ; ; ; ; ; ; ; ; ; ;
Lancet Infect Dis; 2021 Jun; 21(6):e149-e162. PubMed ID: 33333012
[TBL] [Abstract][Full Text] [Related]
78. Proven COVID-19-associated pulmonary aspergillosis in patients with severe respiratory failure.
Fortarezza F; Boscolo A; Pezzuto F; Lunardi F; Jesús Acosta M; Giraudo C; Del Vecchio C; Sella N; Tiberio I; Godi I; Cattelan A; Vedovelli L; Gregori D; Vettor R; Viale P; Navalesi P; Calabrese F
Mycoses; 2021 Oct; 64(10):1223-1229. PubMed ID: 34157166
[TBL] [Abstract][Full Text] [Related]
79. Invasive pulmonary aspergillosis in the intensive care unit: current challenges and best practices.
Gaffney S; Kelly DM; Rameli PM; Kelleher E; Martin-Loeches I
APMIS; 2023 Nov; 131(11):654-667. PubMed ID: 37022291
[TBL] [Abstract][Full Text] [Related]
80. COVID-19-Associated Pulmonary Aspergillosis in a Tertiary Hospital.
Marta GC; Lorena FE; Laura MV; Angela LM; Blanca LG; Rodrigo AA; Marta SG; Santiago MG; Liliana PM; Maria Luisa SN; de la Rasilla Teresa PG
J Fungi (Basel); 2022 Jan; 8(2):. PubMed ID: 35205852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
